Nobel Biocare

Medytox, Inc. Announces the Formation of Luvantas Subsidiary and Appointment of Key Executives

Retrieved on: 
Wednesday, January 3, 2024

IRVINE, Calif., Jan. 3, 2024 /PRNewswire/ -- Medytox, Inc. is pleased to announce the formation of Luvantas, Inc. ( www.luvantas.com ) as its wholly-owned North American subsidiary.

Key Points: 
  • IRVINE, Calif., Jan. 3, 2024 /PRNewswire/ -- Medytox, Inc. is pleased to announce the formation of Luvantas, Inc. ( www.luvantas.com ) as its wholly-owned North American subsidiary.
  • More information on this state-of-the-art formulation of Botulinum toxin will be provided once regulatory approvals are obtained.
  • In connection with the formation of Luvantas, Thomas A. Albright has been appointed its President and CEO and Stephanie A. Yee has been appointed its CFO.
  • As CEO, Tom brings 40 years of healthcare experience to Luvantas with medical aesthetic leadership roles since 2000.

Envista Holdings Corporation Appoints Three New Members to Leadership Team

Retrieved on: 
Thursday, December 14, 2023

Robert Befidi joins Envista from 3M, where he most recently was President of the Separation and Purification Sciences Division, a global filtration technology leader.

Key Points: 
  • Robert Befidi joins Envista from 3M, where he most recently was President of the Separation and Purification Sciences Division, a global filtration technology leader.
  • Suraj Satpathy joins Envista Holdings Corporation from Cepheid, a global diagnostics company under the Danaher Corporation, where he most recently served as the Senior Vice President of Human Resources and Internal Communications.
  • Amir Aghdaei, CEO Envista, is working directly with the Nobel Biocare leadership team to expand the business' capabilities and accelerate growth in 2024 until a permanent successor is named.
  • "Envista and our customers will benefit from the leadership and expertise of Robert, Andrew, and Suraj," said Amir.

BioCare In-House Expertise to Guide Customers on Effectively Preparing for the Drug Supply Chain Security Act (DSCSA)

Retrieved on: 
Thursday, November 9, 2023

The DSCSA final phase includes the enforcement of exchanging serialized data at the package level and kicks in on November 27, 2024.

Key Points: 
  • The DSCSA final phase includes the enforcement of exchanging serialized data at the package level and kicks in on November 27, 2024.
  • As the intermediary between pharmaceutical manufacturers and healthcare providers, BioCare plays a vital role to ensuring the integrity and safety of the pharmaceutical supply chain.
  • By acting as a knowledgeable and supportive bridge between the manufacturers and customer healthcare entities, BioCare effectively enhances compliance and contributes to the overall safety and trustworthiness of the pharmaceutical supply chain.
  • A copy of the BioCare white paper, "The Drug Supply Chain Security Act (DSCSA) & How Companies Can Prepare for Compliance, is available here .

BioCare Named to Inc.'s Second Annual Power Partner Awards

Retrieved on: 
Tuesday, October 24, 2023

TEMPE, Ariz., Oct. 24, 2023 /PRNewswire/ -- Inc. Business Media today announced the second annual Power Partner Awards, honoring B2B organizations across the globe that have proven track records supporting entrepreneurs and helping startups grow. BioCare, a leading specialty pharmaceutical distribution partner known for its specialty distribution and logistics services, was named to the prestigious list. The list recognizes 389 firms in marketing and advertising, health and wellness, financial services, legal, logistics, and productivity, as well as other areas of business.

Key Points: 
  • TEMPE, Ariz., Oct. 24, 2023 /PRNewswire/ -- Inc. Business Media today announced the second annual Power Partner Awards, honoring B2B organizations across the globe that have proven track records supporting entrepreneurs and helping startups grow.
  • BioCare, a leading specialty pharmaceutical distribution partner known for its specialty distribution and logistics services, was named to the prestigious list.
  • All 389 companies received top marks from clients for being instrumental in helping leadership navigate the dynamic world of startups.
  • BioCare focuses on delivering safe, high-quality, innovative therapies for healthcare partners in specialty pharmacies, hospitals, infusion centers and physicians' offices.

Biocare Medical's IntelliPATH FLX™ Automated Slide Stainer: An Integral Part of EmeritusDX's Improved Diagnostic Workflow

Retrieved on: 
Wednesday, October 11, 2023

The integration of Biocare Medical's IntelliPATH FLX™ Automated Slide Stainer combined with Biocare's extensive menu of IHC antibodies, detection kits and ancillary reagents, into EmeritusDX's workflow marks a significant improvement in the efficiency and flexibility of their IHC testing.

Key Points: 
  • The integration of Biocare Medical's IntelliPATH FLX™ Automated Slide Stainer combined with Biocare's extensive menu of IHC antibodies, detection kits and ancillary reagents, into EmeritusDX's workflow marks a significant improvement in the efficiency and flexibility of their IHC testing.
  • Biocare Medical's IntelliPATH FLX™ is an automated slide stainer designed to optimize staining processes by offering a broad menu, precision, control, consistency and reliability.
  • The IntelliPATH FLX™ Automated Slide Stainer has proven essential in the accurate and reliable performance of their extensive IHC menu, including the Bladder17™ IHC test.
  • This partnership between Biocare Medical and EmeritusDX emphasizes a shared commitment to improving diagnostic processes through the effective utilization of innovative technologies and advanced workflow optimization.

BioCare, Inc. Named to 2023 Inc. 5000 List of Fastest-Growing Private Companies for Second Year in a Row

Retrieved on: 
Thursday, August 31, 2023

Notably, BioCare has earned its position on the list for the second consecutive year, claiming the No.

Key Points: 
  • Notably, BioCare has earned its position on the list for the second consecutive year, claiming the No.
  • BioCare, Inc. has secured a place on Inc. 5000's list of fastest-growing private companies for the second year in a row.
  • In all, this year's Inc. 5000 companies have added 1,187,266 jobs to the economy over the past three years.
  • The top 500 companies are featured in the September issue of Inc. magazine, available on newsstands beginning Wednesday, August 23.

Curant Health Partners with BioCareSD and LogiCare3PL to Offer Integrated, Enhanced Product & Patient Journey

Retrieved on: 
Monday, August 28, 2023

Curant Health, a national outcomes-based patient support organization, today announced a partnership with BioCare Inc. companies’ BioCareSD , a leading distributor of life-saving therapies, and LogiCare3PL , BioCare’s 3PL solution.

Key Points: 
  • Curant Health, a national outcomes-based patient support organization, today announced a partnership with BioCare Inc. companies’ BioCareSD , a leading distributor of life-saving therapies, and LogiCare3PL , BioCare’s 3PL solution.
  • This synergy is meant to create an enhanced yet simplified single-source ecosystem, to support the complex rare disease patient and product needs.
  • In addition to shortening the supply chain, best-in-class performance benchmarks will be leveraged to ensure gold standard product and patient journey.
  • “Curant Health is the ideal company to help support the patient journey.”
    “This partnership with BioCareSD and LogiCare3PL will ensure seamless transitions for the rare disease patient circumventing a multitude of gaps patients face in both getting on therapy and staying on therapy.

BioCareSD Builds Depth as Limited Specialty Distributor by Adding ROCTAVIAN™, RYSTIGGO®, VYVGART® HYTRULO to Portfolio

Retrieved on: 
Tuesday, July 11, 2023

TEMPE, Ariz., July 11, 2023 /PRNewswire/ -- BioCareSD is excited to announce the addition of ROCTAVIAN™, RYSTIGGO®, and VYVGART® HYTRULO to their rapidly growing portfolio of life-saving specialty therapies.

Key Points: 
  • TEMPE, Ariz., July 11, 2023 /PRNewswire/ -- BioCareSD is excited to announce the addition of ROCTAVIAN™, RYSTIGGO®, and VYVGART® HYTRULO to their rapidly growing portfolio of life-saving specialty therapies.
  • BioCareSD is part of a limited distribution network for each therapy.
  • BioCareSD announces three new FDA-approved products to growing portfolio of life-saving specialty therapies.
  • VYVGART® HYTRULO is for subcutaneous use only and administered with a winged infusion set by a healthcare professional.

BioCare, Inc. Named to 2023 Financial Times List of The Americas' Fastest Growing Companies

Retrieved on: 
Wednesday, March 29, 2023

TEMPE, Ariz., March 29, 2023 /PRNewswire/ -- BioCare, Inc., a leading specialty pharmaceutical distribution partner that provides distribution, specialty pharmacy, and logistics services, has been recognized by the Financial Times as one of " The Americas' Fastest Growing Companies 2023 ."

Key Points: 
  • TEMPE, Ariz., March 29, 2023 /PRNewswire/ -- BioCare, Inc., a leading specialty pharmaceutical distribution partner that provides distribution, specialty pharmacy, and logistics services, has been recognized by the Financial Times as one of " The Americas' Fastest Growing Companies 2023 ."
  • The list, compiled by the Financial Times with research company Statista, ranks the top 500 companies in the Americas that have achieved the highest compound annual growth in revenues between 2018 and 2021.
  • "We are honored to be recognized as one of America's Fastest Growing Companies by the Financial Times.
  • To be included in the list of the Americas' Fastest-Growing Companies, a company had to meet the following criteria:
    Headquartered in one of 20 American countries.

Revolutionary SENSIL® ByNature Nylon 6.6 Earns ISCC+ Certification to Help Apparel Brands and Retailers Reduce Carbon Footprint

Retrieved on: 
Tuesday, March 14, 2023

NILIT, a global leader in premium Nylon 6.6 for apparel, has earned the International Sustainability and Carbon Certification Plus system (ISCC+) accreditation for its primary SENSIL® ByNature facility in Israel.

Key Points: 
  • NILIT, a global leader in premium Nylon 6.6 for apparel, has earned the International Sustainability and Carbon Certification Plus system (ISCC+) accreditation for its primary SENSIL® ByNature facility in Israel.
  • The ISCC+ system is a globally applicable, independent sustainability certification program that confirms the controlled use of renewable feedstocks throughout a supply chain.
  • The ISCC+ system verifies the origin of the renewable feedstocks in SENSIL® ByNature, the new sustainable Nylon 6.6 with lower environmental impact that offers brands and retailers a high-quality foundation for more ecologically responsive apparel designs.
  • Obtain a list of certified mills who produce sustainable SENSIL® fabrics, including SENSIL® ByNature fabrics, by contacting Amy Holzer at [email protected] .